Indirectly comparing mogamulizumab with evidence from people having standard care in the NHS suggests that people are likely to live longer with mogamulizumab., according to NICE final draft guidance.

OnMedica

Nov 11, 2021

Quality Evidence Briefings Visual Abstracts

Quality Evidence Briefings, Cancer, Oncology, Head and neck cancer, Thoracic cancer , Oncology Room

#VisualAbstract: Low-dose computed tomography improves the detection of secondary primary lung cancers compared to chest radiographs for head and neck cancer survivors

2 Minute Medicine

Nov 10, 2021

OnMedica

Oncology Room

Major centres struggle as cancer waiting time performance hits record low

#VisualAbstract: Patient-led surveillance after treatment of localized melanoma is safe, feasible, and acceptable compared to clinician-led surveillance

Epcoritamab shows promising response rates seen in relapsed or refractory non-Hodgkin lymphoma

#VisualAbstract: Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma

Quick guide on immunisations for cancer patients

Geriatric assessment and management may reduce adverse events in older cancer patients

Osimertinib recommended for lung cancer within CDF

Dabrafenib plus trametinib provides clinically important response rates in BRAF-mutated gliomas

177Lu-Dotatate plus octreotide was not superior in overall survival compared to octreotide alone for neuroendocrine tumours

Selpercatinib recommended for RET fusion-positive advanced lung cancer

#VisualAbstract: Intensive chemotherapy is associated with better long-term survival in older patients with acute myeloid leukemia

Postoperative chemotherapy in chemosensitive patients undergoing surgical treatment of gastric cancer may prolong survival

#VisualAbstract: Assessing early tumour response may prevent patients from experiencing serious immune-related adverse events when undergoing combination nivolumab and ipilimumab therapy for advanced melanoma

NICE recommends nivolumab for adjuvant treatment of some gastrointestinal cancers

#VisualAbstract: High-dose glucocorticoids may be detrimental for the management of patients with advanced melanoma experiencing immune-related adverse events

Adjuvant gefitinib compared to chemotherapy after lung cancer resection did not improve survival

#VisualAbstract: Melanomas diagnosed through routine skin checks were associated with significantly lower mortality rates

#VisualAbstract: Lenalidomide in combination with R-CHOP is effective in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma

#VisualAbstract: Acalabrutinib monotherapy has acceptable tolerability and limited response in patients with Richter transformation

Mogamulizumab recommended for previously treated mycosis fungoides and Sézary syndrome

#VisualAbstract: Low-dose computed tomography improves the detection of secondary primary lung cancers compared to chest radiographs for head and neck cancer survivors

About this room

Oncology Room

About this room

Cookies